Cargando…
Reduced restenosis and enhanced re-endothelialization of functional biodegradable vascular scaffolds by everolimus and magnesium hydroxide
BACKGROUND: Coronary artery disease is a cardiovascular disease with a high mortality and mortality rate in modern society. Vascular stent insertion to restore blood flow is essential to treat this disease. A fully biodegradable vascular scaffold (BVS) is a vascular poly (L-lactic acid) (PLLA) stent...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9768885/ https://www.ncbi.nlm.nih.gov/pubmed/36544178 http://dx.doi.org/10.1186/s40824-022-00334-x |
_version_ | 1784854267963637760 |
---|---|
author | Baek, Seung-Woon Kim, Da-Seul Song, Duck Hyun Kim, Han Byul Lee, Semi Kim, Jun Hyuk Lee, Jun-Kyu Hong, Young Joon Park, Chun Gwon Han, Dong Keun |
author_facet | Baek, Seung-Woon Kim, Da-Seul Song, Duck Hyun Kim, Han Byul Lee, Semi Kim, Jun Hyuk Lee, Jun-Kyu Hong, Young Joon Park, Chun Gwon Han, Dong Keun |
author_sort | Baek, Seung-Woon |
collection | PubMed |
description | BACKGROUND: Coronary artery disease is a cardiovascular disease with a high mortality and mortality rate in modern society. Vascular stent insertion to restore blood flow is essential to treat this disease. A fully biodegradable vascular scaffold (BVS) is a vascular poly (L-lactic acid) (PLLA) stent that is receiving growing interest as this is biodegradable in the body and does not require secondary removal surgery. However, acidic byproducts composed of PLLA produced during the biodegradation of the BVS can induce an inflammatory response. Magnesium hydroxide, a basic inorganic particle, neutralizes the acidic byproducts of PLLA. METHODS: In this study, we investigated using a BVS coated with everolimus and surface-modified magnesium hydroxide that suppresses smooth muscle cell proliferation and protects endothelial cells, respectively. The various characteristics of the functional stent were evaluated using in vitro and in vivo analyses. RESULTS: The BVS was successfully prepared with evenly coated everolimus and surface-modified magnesium hydroxide. A neutral pH value was maintained by magnesium hydroxide during degradation, and everolimus was released for one month. The coated BVS effectively inhibited protein adsorption and platelet adhesion, demonstrating excellent blood compatibility. In vitro analysis showed that BVS protects endothelial cells with magnesium hydroxide and selectively inhibits smooth muscle cell proliferation via everolimus treatment. The functional BVS was inserted into porcine coronary arteries for 28 days, and the results demonstrated that the restenosis and inflammation greatly decreased and re-endothelialization was enhanced as compared to others. CONCLUSIONS: This study provides new insights into the design of drug-incorporated BVS stent for coronary artery disease. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40824-022-00334-x. |
format | Online Article Text |
id | pubmed-9768885 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-97688852022-12-22 Reduced restenosis and enhanced re-endothelialization of functional biodegradable vascular scaffolds by everolimus and magnesium hydroxide Baek, Seung-Woon Kim, Da-Seul Song, Duck Hyun Kim, Han Byul Lee, Semi Kim, Jun Hyuk Lee, Jun-Kyu Hong, Young Joon Park, Chun Gwon Han, Dong Keun Biomater Res Research Article BACKGROUND: Coronary artery disease is a cardiovascular disease with a high mortality and mortality rate in modern society. Vascular stent insertion to restore blood flow is essential to treat this disease. A fully biodegradable vascular scaffold (BVS) is a vascular poly (L-lactic acid) (PLLA) stent that is receiving growing interest as this is biodegradable in the body and does not require secondary removal surgery. However, acidic byproducts composed of PLLA produced during the biodegradation of the BVS can induce an inflammatory response. Magnesium hydroxide, a basic inorganic particle, neutralizes the acidic byproducts of PLLA. METHODS: In this study, we investigated using a BVS coated with everolimus and surface-modified magnesium hydroxide that suppresses smooth muscle cell proliferation and protects endothelial cells, respectively. The various characteristics of the functional stent were evaluated using in vitro and in vivo analyses. RESULTS: The BVS was successfully prepared with evenly coated everolimus and surface-modified magnesium hydroxide. A neutral pH value was maintained by magnesium hydroxide during degradation, and everolimus was released for one month. The coated BVS effectively inhibited protein adsorption and platelet adhesion, demonstrating excellent blood compatibility. In vitro analysis showed that BVS protects endothelial cells with magnesium hydroxide and selectively inhibits smooth muscle cell proliferation via everolimus treatment. The functional BVS was inserted into porcine coronary arteries for 28 days, and the results demonstrated that the restenosis and inflammation greatly decreased and re-endothelialization was enhanced as compared to others. CONCLUSIONS: This study provides new insights into the design of drug-incorporated BVS stent for coronary artery disease. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40824-022-00334-x. BioMed Central 2022-12-21 /pmc/articles/PMC9768885/ /pubmed/36544178 http://dx.doi.org/10.1186/s40824-022-00334-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Baek, Seung-Woon Kim, Da-Seul Song, Duck Hyun Kim, Han Byul Lee, Semi Kim, Jun Hyuk Lee, Jun-Kyu Hong, Young Joon Park, Chun Gwon Han, Dong Keun Reduced restenosis and enhanced re-endothelialization of functional biodegradable vascular scaffolds by everolimus and magnesium hydroxide |
title | Reduced restenosis and enhanced re-endothelialization of functional biodegradable vascular scaffolds by everolimus and magnesium hydroxide |
title_full | Reduced restenosis and enhanced re-endothelialization of functional biodegradable vascular scaffolds by everolimus and magnesium hydroxide |
title_fullStr | Reduced restenosis and enhanced re-endothelialization of functional biodegradable vascular scaffolds by everolimus and magnesium hydroxide |
title_full_unstemmed | Reduced restenosis and enhanced re-endothelialization of functional biodegradable vascular scaffolds by everolimus and magnesium hydroxide |
title_short | Reduced restenosis and enhanced re-endothelialization of functional biodegradable vascular scaffolds by everolimus and magnesium hydroxide |
title_sort | reduced restenosis and enhanced re-endothelialization of functional biodegradable vascular scaffolds by everolimus and magnesium hydroxide |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9768885/ https://www.ncbi.nlm.nih.gov/pubmed/36544178 http://dx.doi.org/10.1186/s40824-022-00334-x |
work_keys_str_mv | AT baekseungwoon reducedrestenosisandenhancedreendothelializationoffunctionalbiodegradablevascularscaffoldsbyeverolimusandmagnesiumhydroxide AT kimdaseul reducedrestenosisandenhancedreendothelializationoffunctionalbiodegradablevascularscaffoldsbyeverolimusandmagnesiumhydroxide AT songduckhyun reducedrestenosisandenhancedreendothelializationoffunctionalbiodegradablevascularscaffoldsbyeverolimusandmagnesiumhydroxide AT kimhanbyul reducedrestenosisandenhancedreendothelializationoffunctionalbiodegradablevascularscaffoldsbyeverolimusandmagnesiumhydroxide AT leesemi reducedrestenosisandenhancedreendothelializationoffunctionalbiodegradablevascularscaffoldsbyeverolimusandmagnesiumhydroxide AT kimjunhyuk reducedrestenosisandenhancedreendothelializationoffunctionalbiodegradablevascularscaffoldsbyeverolimusandmagnesiumhydroxide AT leejunkyu reducedrestenosisandenhancedreendothelializationoffunctionalbiodegradablevascularscaffoldsbyeverolimusandmagnesiumhydroxide AT hongyoungjoon reducedrestenosisandenhancedreendothelializationoffunctionalbiodegradablevascularscaffoldsbyeverolimusandmagnesiumhydroxide AT parkchungwon reducedrestenosisandenhancedreendothelializationoffunctionalbiodegradablevascularscaffoldsbyeverolimusandmagnesiumhydroxide AT handongkeun reducedrestenosisandenhancedreendothelializationoffunctionalbiodegradablevascularscaffoldsbyeverolimusandmagnesiumhydroxide |